Canada· CA-DIN-02528339
SCEMBLIX
A asciminib product containing asciminib (asciminib hydrochloride), registered in Canada by NOVARTIS PHARMACEUTICALS CANADA INC. The same ATC class is registered in 16 of our 19 countries.
Checked against Health Canada Drug Product Database (Canada) on
Informational only — not a medical device.
Where it is registered
Asciminib is registered in 16 of 19 countries.
Countries holding a registration under ATC L01EA06 (asciminib), each read from that country’s own register.
- This record: Canada, from Health Canada Drug Product Database (Canada)
- 10 of them publish a price we can compare per daily dose
Asciminib · ATC L01EA06
16 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of asciminib costs, country by country.
Normalised to the WHO defined daily dose (80 mg), the median price runs from $0.27 in France to $162.23 in Switzerland — a ×606 gap.
- 2 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Asciminib · price per daily dose (80 mg)
USD · FX 28 Sept 2026
- CH Switzerland$162.23
- FR France$0.27
The record
At a glance
Health Canada Drug Product Database (Canada)- Active substance
- ASCIMINIB (ASCIMINIB HYDROCHLORIDE)
- Manufacturer
- NOVARTIS PHARMACEUTICALS CANADA INC
- Country
- Canada (CA)
- ATC code
- L01EA06
- ATC class
- Asciminib
- Defined daily dose
- 80 mg, O
- Reimbursed
- Not published by this register
- Source register
- Health Canada Drug Product Database (Canada)
- Last checked
- October 1, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Asciminib in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomAsciminib 40mg tabletsNovartis Pharmaceuticals UK Ltd
- CzechiaSCEMBLIXNovartis Europharm Limited, Dublin
- SpainSCEMBLIX 100 MG COMPRIMIDOS RECUBIERTOS CON PELICULANovartis Europharm Limited
- FinlandScemblixNovartis Europharm Limited
- United StatesSCEMBLIXNovartis Pharmaceuticals Corporation
- SwitzerlandScemblix 100 mg, FilmtablettenNovartis Pharma Schweiz AG
- IcelandScemblixNovartis Europharm Limited*
- NetherlandsScemblix 100 mg, filmomhulde tabletNovartis Europharm Limited
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Scemblix
- Liechtenstein · Scemblix
- Norway · Scemblix
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Health Canada Drug Product Database (Canada). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/6a3ca2e3-c356-44af-af88-887d02adb812 GET /v1/drugs/6a3ca2e3-c356-44af-af88-887d02adb812?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"din": "02528339",
"form": "TABLET",
"class": "Human",
"routes": [
"ORAL"
],
"source": "health_canada_dpd",
"status": "MARKETED",
"atc_raw": "L01EA06",
"schedule": [
"Prescription"
],
"drug_code": "101757",
"strengths": [
"40 MG"
],
"ahfs_class": null,
"substances": [
"ASCIMINIB (ASCIMINIB HYDROCHLORIDE)"
],
"product_categorization": null
}See everything about asciminib.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.